East Asia Pharmaceutical Co., Ltd.: The net profit attributable to the parent company in the first half of the year was a loss of 30.2283 million yuan.

Dongya Pharmaceutical disclosed its semi-annual report on August 28, with the company achieving operating income of 416 million yuan in the first half of the year, a year-on-year decrease of 35.85%; the net profit attributable to shareholders of the listed company was a loss of 30.2283 million yuan, with a basic earnings per share of -0.26 yuan/share.